Hemostats Market Analysis | United States | 2016-2022 | MedCore

  • Year: 2016
  • Scope: 2012-2022
  • Region: United States
  • Pages: 55
  • Published Date: 8/1/2016
  • Type: MedCore

Product Description

Thrombin has traditionally been the most popular hemostat due to its ability to rapidly cause clotting. However, as physicians become more aware of some of the safety concerns relating to using thrombin products, they will move towards plant-based and combination products, which are either more affordable or effective. Collagen-based hemostats represented the smallest segment in 2015, and will continue to do so through 2020. These hemostats are a well-established technology and will continue to have a stable presence in the market. Preferences for combination products that contain collagen will take market share from the collagen-only segment. Collagen-based hemostats have potential side effects which will limit the market. Over the forecast period, combination hemostats are expected to grow steadily and will overtake thrombin hemostats to represent the majority of the market. Many competitors have been putting a greater focus on their combination products. In addition, several products in this market are approved for multiple indications and surgical specialties, which creates greater growth potential in the market.
 

FREE Sample Report



The "US Market Report Suite for Wound and Tissue Management 2016 - MedSuite" includes analysis on the following companies currently active in this market:
Ethicon
Covidien
Acelity (KCI/Systagenix)
Medline
3M
Baxter
ConvaTec
Smith & Nephew
Mölnlycke
MiMedx
Pfizer
Integra Lifesciences
BSN Medical
Organogenesis
C. R. Bard
ArjoHuntleigh
Sanofi Genzyme
Osiris
mediUSA
Medicines Company
SIGVARIS
CryoLife
Aesculap USA
Z-Medica
Bio Compression Systems
Acell
Hartmann
Juzo
Teleflex
Stryker
Vascular Solutions
Derma Sciences
Lympha Press
Tactile Medical
Andover Healthcare
Albahealth
MCS
Circulator Boot Corporation
Celox
Carolon
Others include: Ackerman, Applied Medical, Adhezion Biomedical, Hartmann, Purple Surgical, Reach Surgical, Frankenman, ConMed, Cardinal Health, Chemence Medical, Dermarite Industries, Mckesson, Surgical Specialties, Codman, SunMedix, DeRoyal, Beiersdorf, Karl Storz, Kimberly Clark, Medlogic, Microline Surgical, Airway Surgical Appliances (Trueform), Ames Walker, Allegro, Dynarex Inc, Elastic Therapy Inc. (DJO), Graham-Field, Lohmann & Rauscher, Robinson Healthcare, Therafirm, SmartKnit, Venosan, DJO, Currie Medical, Normatec, ThermoTek, Alliqua Biomedical, Coloplast, Gentell, Hollister, Ferris Mfg CorpSteadmed Medical, Mckesson, MPM Medical, MediPurpose, Reliamed, Allosource, Soluble Systems, Johnson & Johnson, Human Biosciences, MTF Wound care, RTI Surgical, Xtant Medical, Stryker, Tissue Regenix, Promethean Life Sciences, Becton Dickinson, HemCon, Merit Medical, Hemostasis LLC, Marine Polymer Technologies, Cohera Medical, Hyperbranch Medical, Mallinckrodt, Ocular Therapeutix, Scion Cardiovascular, Atmos, Boehringer Wound Systems, Equinox Medical, Devon Medical SystemsInvacare, Genadyne, Medela, Premco Medical Sytems, Prospera NPWT, Talley Medical and others.
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary

FREE

Select License Type

Hemostats, also known as anti-hemorrhagic agents are substances that promote hemostasis, the process which causes bleeding to stop. There are a number of topical hemostats used in surgeries. Topical hemostats are suitable for minor bleeding and oozing blood from injured capillaries and venules. Physiologic hemostasis occurs with vascular constriction and is a complex process in which blood changes from a fluid to a solid state in order to control tissue damage and bleeding. Thrombin binds to platelets and becomes activated. They activate fibrinogen into fibrin. The fibrin monomers combine to create fibrin structures that coagulate open arteries. Platelets aggregate at the injury site (the surgical incision) to form a temporary plug.

  • 2016
  • 2012-2022
  • United States
  • 8/1/2016
  • 55
  • MedCore
0
    0
    Your Cart
    Your cart is emptyReturn to Report Library